Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation
- 1 January 2003
- journal article
- basic science
- Published by Wolters Kluwer Health in AIDS
- Vol. 17 (2) , 157-166
- https://doi.org/10.1097/00002030-200301240-00004
Abstract
Objective: A live attenuated SIV vaccine strain, termed SIVmac239Δ3 and containing large deletions in nef, vpr and the negative regulatory element, was previously shown to cause AIDS mostly in monkeys vaccinated as infants. In the present study, we demonstrate that SIVmac239Δ3 is pathogenic in most vaccinated adult monkeys, given enough time. Methods: Eleven rhesus macaques vaccinated as adults with SIVmac239Δ3 were followed for extended periods (up to 6.8 years). Results: We found signs of immune dysregulation in all 11 adult vaccinees. All animals developed persistently inverted CD4 : CD8 T-cell ratios, seven (64%) had persistent recurrent viremia, and six (55%) had decreased CD4 T-cell counts (< 500 × 106 cells/l). Further signs included low CD4CD29 lymphocyte subsets, loss of anti-Gag antibodies, anemia, thrombocytopenia, wasting, and opportunistic infections. Two adult vaccinees (18%) subsequently developed AIDS. Development of chronic, recurrent viremia with plasma viral RNA loads ≥ 103 copies/ml and cytoviremia was a poor prognostic sign. Conclusion: Our data demonstrate that with time, a live attenuated, multiply deleted SIV vaccine can cause immune dysregulation in most vaccine recipients, even in initially immune competent, healthy adults. Immune dysfunction can progress to full AIDS. However, pathogenic effects became evident only several years after vaccination. Thus, mass vaccination of humans with similarly constructed live attenuated HIV vaccines, recently suggested for countries with high HIV-1 transmission rates, seems contraindicated.Keywords
This publication has 72 references indexed in Scilit:
- Live attenuated AIDS viruses as vaccines: promise or peril?Immunological Reviews, 1999
- Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virusJournal of General Virology, 1996
- Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletionImmunology Letters, 1996
- Protection from Pathogenic SIVmac Challenge Following Short-Term Infection with a Nef-Deficient Attenuated VirusVirology, 1996
- Simian Immunodeficiency Virus Live and Inactivated Experimental VaccinesAIDS Research and Human Retroviruses, 1996
- Cellular Immune Response of Rhesus Monkeys Infected with a Partially Attenuated nef Deletion Mutant of the Simian Immunodeficiency VirusVirology, 1995
- Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cellsThe Lancet, 1995
- Pathogenicity of Live, Attenuated SIV After Mucosal Infection of Neonatal MacaquesScience, 1995
- Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variantsJournal of General Virology, 1994
- Protective Effects of a Live Attenuated SIV Vaccine with a Deletion in the nef GeneScience, 1992